Eeva Lukkari‐Lax
About
Eeva Lukkari‐Lax is a scholar working on Public Health, Environmental and Occupational Health, Obstetrics and Gynecology and Reproductive Medicine.
According to data from OpenAlex, Eeva Lukkari‐Lax has authored 23 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Public Health, Environmental and Occupational Health, 10 papers in Obstetrics and Gynecology and 10 papers in Reproductive Medicine. Recurrent topics in Eeva Lukkari‐Lax's work include Reproductive Health and Contraception (18 papers), Ectopic Pregnancy Diagnosis and Management (8 papers) and Endometriosis Research and Treatment (7 papers). Eeva Lukkari‐Lax is often cited by papers focused on Reproductive Health and Contraception (18 papers), Ectopic Pregnancy Diagnosis and Management (8 papers) and Endometriosis Research and Treatment (7 papers). Eeva Lukkari‐Lax collaborates with scholars based in Germany, United States and Finland. Eeva Lukkari‐Lax's co-authors include Jeffrey T. Jensen, François Bissonnette, Andrew M. Kaunitz, Ilza Monteiro, Kristina Gemzell‐Danielsson, Michel Fortier, Jan Endrikat, Dan Apter, Michael Kunz and Hanna Tainio and has published in prestigious journals such as American Journal of Obstetrics and Gynecology, Fertility and Sterility and Obstetrics and Gynecology.
In The Last Decade
Eeva Lukkari‐Lax
21 papers receiving 389 citations
Peers
Eeva Lukkari‐Lax
Hüsnü Görgen Türkiye
Rafael Mendes Moroni Brazil
M. Rocca Italy
Mahmoud S. Zakherah Egypt
Ayman Shehata Dawood Egypt
Mete Işıkoğlu Türkiye
Surasak Angsuwathana Thailand
Özkan Özdamar Türkiye
Alper Başbuğ Türkiye
Claudio Villarroel Chile
Citations per year, relative to Eeva Lukkari‐Lax Eeva Lukkari‐Lax (= 1×)
peers
Hüsnü Görgen
Countries citing papers authored by Eeva Lukkari‐Lax
Since
Specialization
Citations
This map shows the geographic impact of Eeva Lukkari‐Lax's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eeva Lukkari‐Lax with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eeva Lukkari‐Lax more than expected).
Fields of papers citing papers by Eeva Lukkari‐Lax
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Eeva Lukkari‐Lax. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eeva Lukkari‐Lax. The network helps show where Eeva Lukkari‐Lax may publish in the future.
Co-authorship network of co-authors of Eeva Lukkari‐Lax
This figure shows the co-authorship network connecting the top 25 collaborators of Eeva Lukkari‐Lax. A scholar is included among the top collaborators of Eeva Lukkari‐Lax based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eeva Lukkari‐Lax. Eeva Lukkari‐Lax is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Jensen, Jeffrey T., et al.. (2023). Extended use of levonorgestrel-releasing intrauterine system (LNG-IUS) 52 mg: A population pharmacokinetic approach to estimate in vivo levonorgestrel release rates and systemic exposure including comparison with two other LNG-IUSs. Contraception. 120. 109954–109954.
2.
Fels, Lueder, Dustin Costescu, Carolina Sales Vieira, et al.. (2022). The effect of a combined indomethacin and levonorgestrel-releasing intrauterine system on short-term postplacement bleeding profile: a randomized proof-of-concept trial. American Journal of Obstetrics and Gynecology. 228(3). 322.e1–322.e15.
3.
Jensen, Jeffrey T., et al.. (2022). Contraceptive Efficacy and Safety of 52 mg Levonorgestrel-Releasing Intrauterine Systems During Years 6–8 of Use: Data From the Mirena Extension Trial [A13]. Obstetrics and Gynecology. 139(1). 4S–4S.
4.
Jensen, Jeffrey T., et al.. (2022). Estimating In Vivo Levonorgestrel Release Rate and Exposure Over Eight Years With Levonorgestrel Releasing Intrauterine System 52 mg Use With Population Pharmacokinetic Approach [A03]. Obstetrics and Gynecology. 139(1). 1S–1S.
5.
Gemzell‐Danielsson, Kristina, et al.. (2021). More than just contraception: the impact of the levonorgestrel-releasing intrauterine system on public health over 30 years. BMJ Sexual & Reproductive Health. 47(3). 228–230.
6.
Gemzell‐Danielsson, Kristina, et al.. (2021). Thirty years of mirena: A story of innovation and change in women’s healthcare. Acta Obstetricia Et Gynecologica Scandinavica. 100(4). 614–618.
7.
Gemzell‐Danielsson, Kristina, Dan Apter, Eeva Lukkari‐Lax, Katrin Roth, & Marco Serrani. (2017). Overcoming barriers to levonorgestrel-releasing intrauterine system placement: an evaluation of placement of LNG-IUS 8 using the modified EvoInserter ® in a majority nulliparous population. Contraception. 96(6). 426–431.
8.
Kang, Sukho, Mulan Ren, Edith Weisberg, et al.. (2016). A single-arm phase III study exploring the efficacy and safety of LNG-IUS 8, a low-dose levonorgestrel intrauterine contraceptive system (total content 13.5 mg), in an Asia-Pacific population. Contraception. 95(4). 371–377.
9.
Apter, Dan, Paula Briggs, Marjo Tuppurainen, et al.. (2016). A 12-month multicenter, randomized study comparing the levonorgestrel intrauterine system with the etonogestrel subdermal implant. Fertility and Sterility. 106(1). 151–157.e5.
10.
Gemzell‐Danielsson, Kristina, et al.. (2016). A Phase III, single-arm study of LNG-IUS 8, a low-dose levonorgestrel intrauterine contraceptive system (total content 13.5mg) in postmenarcheal adolescents. Contraception. 93(6). 507–512.
11.
Gemzell‐Danielsson, Kristina, Kai J. Bühling, Eeva Lukkari‐Lax, et al.. (2014). A multicenter, open-label, single-arm study exploring the safety of a new 13.5 mg total dose levonorgestrel intrauterine contraceptive system in postmenarcheal adolescents. Fertility and Sterility. 102(3). e12–e13.
12.
Gemzell‐Danielsson, Kristina, et al.. (2014). A phase III single-arm study of a new 13.5 mg levonorgestrel intrauterine contraceptive system in postmenarcheal adolescents: an evaluation of efficacy, bleeding, user satisfaction, and placement. Fertility and Sterility. 102(3). e141–e142.
13.
Tuppurainen, M., et al.. (2014). A 12-month multicenter, randomized phase III study comparing a 13.5 mg levonorgestrel intrauterine contraceptive system with the etonogestrel subdermal contraceptive implant in women aged 18–35 years. Fertility and Sterility. 102(3). e142–e142.
14.
Jensen, Jeffrey T., Diana Mansour, Eeva Lukkari‐Lax, et al.. (2012). Bleeding patterns with the levonorgestrel-releasing intrauterine system when used for heavy menstrual bleeding in women without structural pelvic pathology: a pooled analysis of randomized controlled studies. Contraception. 87(1). 107–112.
15.
Kaunitz, Andrew M., et al.. (2012). Levonorgestrel-releasing intrauterine system for heavy menstrual bleeding improves hemoglobin and ferritin levels. Contraception. 86(5). 452–457.
16.
Endrikat, Jan, et al.. (2011). The levonorgestrel-releasing intrauterine system provides a reliable, long-term treatment option for women with idiopathic menorrhagia. Archives of Gynecology and Obstetrics. 285(1). 117–121.
17.
Kaunitz, Andrew M., et al.. (2010). Levonorgestrel-Releasing Intrauterine System or Medroxyprogesterone for Heavy Menstrual Bleeding. Obstetrics and Gynecology. 116(3). 625–632.
18.
Depypere, Herman, et al.. (2010). A 60-month non-comparative study on bleeding profiles with the levonorgestrel intrauterine system from the late transition period to estrogen supplemented menopause. European Journal of Obstetrics & Gynecology and Reproductive Biology. 153(2). 176–180.
19.
Endrikat, Jan, Heather Shapiro, Eeva Lukkari‐Lax, et al.. (2009). A Canadian, Multicentre Study Comparing the Efficacy of a Levonorgestrel-releasing Intrauterine System to an Oral Contraceptive in Women With Idiopathic Menorrhagia. Journal of Obstetrics and Gynaecology Canada. 31(4). 340–347.
20.
Kaunitz, Andrew M., et al.. (2009). Levonorgestrel intrauterine system and medroxyprogesterone acetate for treatment of heavy menstrual bleeding. Contraception. 80(2). 212–212.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Hüsnü Görgen Breakdown of academic impact, for papers by Rafael Mendes Moroni Breakdown of academic impact, for papers by M. Rocca Breakdown of academic impact, for papers by Mahmoud S. Zakherah Breakdown of academic impact, for papers by Ayman Shehata Dawood Breakdown of academic impact, for papers by Mete Işıkoğlu Breakdown of academic impact, for papers by Surasak Angsuwathana Breakdown of academic impact, for papers by Özkan Özdamar Breakdown of academic impact, for papers by Alper Başbuğ Breakdown of academic impact, for papers by Claudio Villarroel